COVID Updates: FDA expands eligibility for remdesivir

on Friday, the agency expanded the use to include everyone who tests positive for the disease, but is not hospitalized, has mild to moderate symptoms, and is at high risk of severe illness.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting